Skip to main content
ROIV logo
ROIV
(NASDAQ)
Roivant Sciences Ltd.
$32.21-- (--)
Loading... - Market loading

Roivant Sciences Ltd. (ROIV) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Roivant Sciences Ltd. stock.

Analyst Consensus Rating

Investment consensus from 10 professional research analysts

Consensus Rating

Buy
Based on 10 unique analysts
(11 total ratings in last 90 days)
High Confidence:1 Buy/Sell

Average Price Target

$36.48
13.26% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest ROIV Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Yatin Suneja
Guggenheim
BuyMaintains
$30.00 $36.00
Brian Cheng
JP Morgan
BuyMaintains
$35.00 $40.00
Chi Meng Fong
BofA Securities
HoldMaintains
$29.50 $31.50
PerPlexity Biotechnology
TipRanks - PerPlexity
BuyDowngrades
$29.00 $36.00
OpenAI Biotechnology
TipRanks - OpenAI
HoldReiterates
$29.00 $35.00
Douglas Tsao
HC Wainwright
BuyReiterates
$34.00
Yasmeen Rahimi
Piper Sandler
BuyMaintains
$40.00
Samantha Semenkow
Citi
BuyReiterates
$35.00 $42.00
Yaron Werber
TD Cowen
BuyReiterates
$29.29
Yasmeen Rahimi
Piper Sandler
BuyMaintains
$22.00 $40.00
Corinne Johnson
Goldman Sachs
BuyMaintains
$38.00 $41.00

Frequently Asked Questions

What is the analyst consensus rating for ROIV?

The analyst consensus rating for ROIV is "Buy" based on 10 analyst recommendations.

What is the average price target for ROIV?

The average 12-month price target for ROIV is $36.48, representing an upside of 13.3% from the current price of $32.21.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.